Wilke, C;
Haas, E;
Reetz, K;
Faber, J;
Garcia-Moreno, H;
Santana, MM;
van de Warrenburg, B;
... Synofzik, M; + view all
(2020)
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
EMBO Molecular Medicine
, Article e11803. 10.15252/emmm.201911803.
Preview |
Text
emmm.201911803.pdf - Published Version Download (2MB) | Preview |
Abstract
With molecular treatments coming into reach for spinocerebellar ataxia type 3 (SCA3), easily accessible, cross-species validated biomarkers for human and preclinical trials are warranted, particularly for the preataxic disease stage. We assessed serum levels of neurofilament light (NfL) and phosphorylated neurofilament heavy (pNfH) in ataxic and preataxic subjects of two independent multicentric SCA3 cohorts and in a SCA3 knock-in mouse model. Ataxic SCA3 subjects showed increased levels of both NfL and pNfH. In preataxic subjects, NfL levels increased with proximity to the individual expected onset of ataxia, with significant NfL elevations already 7.5 years before onset. Cross-sectional NfL levels correlated with both disease severity and longitudinal disease progression. Blood NfL and pNfH increases in human SCA3 were each paralleled by similar changes in SCA3 knock-in mice, here also starting already at the presymptomatic stage, closely following ataxin-3 aggregation and preceding Purkinje cell loss in the brain. Blood neurofilaments, particularly NfL, might thus provide easily accessible, cross-species validated biomarkers in both ataxic and preataxic SCA3, associated with earliest neuropathological changes, and serve as progression, proximity-to-onset and, potentially, treatment-response markers in both human and preclinical SCA3 trials.
Type: | Article |
---|---|
Title: | Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.15252/emmm.201911803 |
Publisher version: | http://dx.doi.org/10.15252/emmm.201911803 |
Language: | English |
Additional information: | © 2020 The Authors. Published under the terms of the CC BY 4.0 license |
Keywords: | knock-in mouse model, neurofilament light chain, phosphorylated neurofilament heavy chain, presymptomatic stage, spinocerebellar ataxia type 3 |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences |
URI: | https://discovery.ucl.ac.uk/id/eprint/10102183 |
Archive Staff Only
View Item |